Open AccessIntravitreal PRN ranibizumab treatment for macular edemadue to branch retinal vein occlusion
Author(s) -
Hasan Basri Çakmak,
Mücella Arıkan Yorgun,
Yasin Toklu,
Melek Mutlu
Publication year - 2017
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1509-39
Subject(s) - medicine , branch retinal vein occlusion , ranibizumab , pro re nata , ophthalmology , macular edema , visual acuity , retinal , bevacizumab , surgery , chemotherapy
To evaluate the effect of intravitreal pro re nata (PRN) ranibizumab treatment from the start on the best-corrected visual acuity (BCVA) and the central retinal thickness (CRT) in macular edema (ME) due to branch retinal vein occlusion (BRVO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom